☰
  • Home
  • Blog
  • Policy Papers
  • Analysis
  • Report Cards
  • Summits
  • You’re Invited
Logo
  • Blog
  • Policy Papers
  • Report Cards
  • Analysis
  • Summits

ICER Mixes Up Priorities in Asthma Drug Review

October 15, 2021

ICER’s priorities differ from severe asthma patients’, and the economists’ approach could make it harder for patients to access the treatment they need.

View Infographic

Tags: ICER, Respiratory

Categorized in: Analysis

Recent Blog Posts

Narrowing the Gout Information Gap May 20, 2022
Countering a Lack of Information and Loss of Hope for Gout Patients May 19, 2022
Pharmacists Poised to Play Larger Role in Uptake of Biosimilars May 13, 2022

2020 K Street NW, Suite 505 Washington, DC 20006 (202) 964-2624

About Us Archive

© 2022 Copyright Institute for Patient Access